NDAORALSUSPENSION, EXTENDED RELEASE
Approved
May 2024
Lifecycle
Growth
Competitive Pressure
0/100
Data completeness
3/8 — Basic
ONYDA XR (clonidine hydrochloride) by Teva is 2 -adrenergic receptors in the brain. First approved in 2024.
Drug data last refreshed 1h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ONYDA XR is an extended-release oral suspension formulation of clonidine hydrochloride, a centrally-acting alpha-2 adrenergic agonist approved in May 2024. It is indicated for ADHD, though its precise mechanism in this condition remains incompletely understood. Clonidine works by stimulating alpha-2 adrenergic receptors in the brain and is not a CNS stimulant.
Growth15.1 years to LOE
Early-stage product with significant commercial upside; brand teams are building from launch foundation with typical growth-phase headcount expansion.
Mechanism of Action
2 -adrenergic receptors in the brain. Clonidine is not a central nervous system stimulant. The mechanism of action of clonidine in ADHD is not known.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ONYDA XR represents a growth-stage specialty product in a high-volume therapeutic area (ADHD) with significant U.S. market potential. Professionals joining the brand team will engage in launch-phase execution, payer negotiations, provider education, and differentiation against established competitors in a dynamic market.
Brand ManagerSenior Medical Science Liaison
Worked on ONYDA XR at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.